|
| US4292299 | 7 Jul 1980 | 29 Sep 1981 | Teijin Limited | Slow-releasing medical preparation to be administered by adhering to a wet mucous surface |
| US4432964 | 27 Dic 1982 | 21 Feb 1984 | ALZA Corporation | Topical composition containing steroid in two forms released independently from polymeric carrier |
| US4478818 | 5 Ene 1984 | 23 Oct 1984 | Alza Corporation | Ocular preparation housing steroid in two different therapeutic forms |
| US4667032 | 10 Oct 1985 | 19 May 1987 | Merck Frosst Canada, Inc. | Phenothiazone derivatives and analogs |
| US4764378 | 10 Feb 1986 | 16 Ago 1988 | Zetachron, Inc. | Buccal drug dosage form |
| US4859667 | 14 Ene 1987 | 22 Ago 1989 | Merck Frosst Canada, Inc. | Pharmaceutical compositions of phenothiazone derivatives and analogs |
| US4889720 | 31 Ago 1987 | 26 Dic 1989 | Teikoku Seiyaku Kabushiki Kaisha | Sustained release dosage form for use with tissues of the oral cavity |
| US4892736 | 3 Jun 1988 | 9 Ene 1990 | The Forsyth Dental Infirmary for Children | Intra-pocket drug delivery devices for treatment of periodontal diseases |
| US4969871 | 15 Feb 1989 | 13 Nov 1990 | Alza Corporation | Intravenous system for delivering a beneficial agent |
| US4985016 | 15 Feb 1989 | 15 Ene 1991 | ALZA Corporation | Intravenous system for delivering a beneficial agent |
| US5017371 | 6 Ene 1988 | 21 May 1991 | Amarillo Cell Culture Company, Incorporated | Method for reducing side effects of cancer therapy |
| US5019382 | 17 Ene 1990 | 28 May 1991 | The Texas A&M University System | Treatment of immuno-resistant disease with low-dose interferon |
| US5045059 | 15 Ago 1990 | 3 Sep 1991 | Alza Corporation | Intravenous system for delivering a beneficial agent |
| US5104899 | 13 Ago 1990 | 14 Abr 1992 | Sepracor, Inc. | Methods and compositions for treating depression using optically pure fluoxetine |
| US5160320 | 12 Ago 1991 | 3 Nov 1992 | Alza Corporation | Intravenous system for delivering a beneficial agent |
| US5173302 | 28 Sep 1990 | 22 Dic 1992 | Medtronic, Inc. | Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs |
| US5250028 | 9 Ago 1991 | 5 Oct 1993 | ALZA Corporation | Intravenous system for delivering a beneficial agent using permeability enhancers |
| US5410054 | 20 Jul 1993 | 25 Abr 1995 | Merck Frosst Canada, Inc. | Heteroaryl quinolines as inhibitors of leukotriene biosynthesis |
| US5589511 | 15 Abr 1994 | 31 Dic 1996 | Sepracor Inc. | Method for treating migraine headaches using optically pure S(+) fluoxetine |
| US5648396 | 7 Jun 1995 | 15 Jul 1997 | Sepracor Inc. | Methods for treating depression and other disorders using optically pure R (-) fluoxetine and monoamine oxidase inhibitor |
| US5708035 | 22 May 1995 | 13 Ene 1998 | Sepracor Inc.
McLean Hospital | Methods of use and compositions of R(-) fluoxetine |
| US5830456 | 13 Sep 1994 | 3 Nov 1998 | The Texas A&M University System | Treatment of viral disease with oral interferon-.alpha. |
| US5910304 | 28 Abr 1992 | 8 Jun 1999 | Texas A&M University System | Low-dose oral administration of interferons |
| US5939426 | 28 Feb 1997 | 17 Ago 1999 | Sepracor Inc. | Methods for treating urinary incontinence using descarboethoxyloratadine |
| US5962464 | 6 Jul 1998 | 5 Oct 1999 | Sepracor Inc. | Methods and compositions for treating allergic asthma using descarboethoxyloratadine |
| US6048879 | 14 Jun 1999 | 11 Abr 2000 | Sepracor Inc. | Methods for treating apnea, apnea disorders, bulimia, and other disorders using optically pure (+) norcisapride |
| US6054463 | 17 Mar 1999 | 25 Abr 2000 | Sepracor Inc. | Methods for treating dermatitis using descarboethoxyloratadine |
| US6100274 | 7 Jul 1999 | 8 Ago 2000 | Schering Corporation | 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions |
| US6110973 | 28 Ene 1999 | 29 Ago 2000 | Sepracor | Methods for treating obesity and weight gain using optically pure (-)-bupropion |
| US6114346 | 22 Oct 1999 | 5 Sep 2000 | Schering Corporation | Treating sleep disorders using desloratadine |
| US6197788 | 27 Sep 1999 | 6 Mar 2001 | Vernalis Research Limited | (-)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders |
| US6265414 | 3 May 2000 | 24 Jul 2001 | Schering Corporation | Treating sleep disorders using desloratadine |
| US6277887 | 20 Abr 2000 | 21 Ago 2001 | Sepracor, Inc. | Methods for treating Parkinson's disease using optically pure (-)-bupropion |
| US6331571 | 11 Ago 1999 | 18 Dic 2001 | Sepracor, Inc. | Methods of treating and preventing attention deficit disorders |
| US6337328 | 18 Ago 2000 | 8 Ene 2002 | Sepracor, Inc. | Bupropion metabolites and methods of use |
| US6339106 | 14 Sep 2000 | 15 Ene 2002 | Sepracor, Inc. | Methods and compositions for the treatment and prevention of sexual dysfunction |
| US6342496 | 22 Feb 2000 | 29 Ene 2002 | Sepracor Inc. | Bupropion metabolites and methods of use |
| US6342533 | 30 Nov 1999 | 29 Ene 2002 | Sepracor, Inc. | Derivatives of ( |
| US6353005 | 22 Feb 2000 | 5 Mar 2002 | Sepracor, Inc. | Method and compositions using ( |
| US6369079 | 29 Feb 2000 | 9 Abr 2002 | Sepracor, Inc. | Methods for treating irritable bowel syndrome using optically pure ( |
| US6369113 | 27 Jun 2001 | 9 Abr 2002 | Sepracor, Inc. | Method for treating depression using optically pure ( |
| US6399826 | 11 Ene 2000 | 4 Jun 2002 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
| US6410052 | 10 Ago 2000 | 25 Jun 2002 | Purdue Research Foundation
Pharmanex, Inc. | Tea catechins in sustained release formulations as cancer specific proliferation inhibitors |
| US6428818 | 17 Ago 2000 | 6 Ago 2002 | Purdue Research Foundation
Pharmanex, Inc. | Tea catechin formulations and processes for making same |
| US6432446 | 1 Feb 2001 | 13 Ago 2002 | Bridge Pharma, Inc. | Non-arrhythmogenic metabolite of oxybutynin |
| US6451860 | 19 Feb 2002 | 17 Sep 2002 | Sepracor, Inc. | Methods for treating depression and other disorders using optically pure ( |
| US6458374 | 28 Ene 1999 | 1 Oct 2002 | Sepracor, Inc. | Methods and compositions for treating chronic disorders using optically pure ( |
| US6476078 | 29 Ene 2001 | 5 Nov 2002 | Sepracor, Inc. | Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction |
| US6495605 | 13 Mar 2001 | 17 Dic 2002 | Sepracor Inc. | Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure ( |
| US6538034 | 4 Dic 2001 | 25 Mar 2003 | | Methods of treating or preventing weight gain, obesity, and related disorders |
| US6548082 | 29 Feb 2000 | 15 Abr 2003 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure R( |
| US6548518 | 10 Ene 2002 | 15 Abr 2003 | Sepracor, Inc. | Methods of treating gastro-esophogeal reflux disease using (-) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| US6552045 | 10 Ene 2002 | 22 Abr 2003 | Sepracor Inc. | Methods and compositions using ( |
| US6559165 | 28 Nov 2000 | 6 May 2003 | Sepracor, Inc. | Methods for treating bulimia using optically pure ( |
| US6559188 | 15 Sep 2000 | 6 May 2003 | Novartis AG | Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes |
| US6610887 | 12 Abr 2002 | 26 Ago 2003 | Sepracor Inc. | Methods of preparing didesmethylsibutramine and other sibutramine derivatives |
| US6649183 | 1 Nov 2001 | 18 Nov 2003 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure R( |
| US6664397 | 22 Nov 1999 | 16 Dic 2003 | Vernalis Research Limited | Use of ( |
| US6709676 | 19 Jun 2002 | 23 Mar 2004 | Schering Corporation | Extended release oral dosage composition |
| US6710087 | 4 Jun 2002 | 23 Mar 2004 | Sepracor, Inc. | Methods of treating or preventing neuropathic pain using sibutramine metabolites |
| US6734213 | 17 May 2002 | 11 May 2004 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
| US6825205 | 24 Sep 2003 | 30 Nov 2004 | Euro-Celtique S.A. | N-substituted hydromorphones and the use thereof |
| US6835740 | 15 Feb 2002 | 28 Dic 2004 | Sepracor Inc. | Methods for treating sleep apnea and sleep induced apnea using optically pure ( |
| US6855820 | 17 May 2002 | 15 Feb 2005 | SmithKline Beecham Corporation | Pharmaceutically active morpholinol |
| US6858589 | 23 Jul 2002 | 22 Feb 2005 | Pharmacy and Therapeutic Advisory Consultancy Pty LTD | Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| US6878713 | 12 Dic 2002 | 12 Abr 2005 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| US6878749 | 16 Ene 2003 | 12 Abr 2005 | Novartis AG | Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| US6894189 | 20 Ago 2003 | 17 May 2005 | Sepracor Inc. | Methods of preparing didesmethylsibutramine and other sibutramine derivatives |
| US6911479 | 19 Ago 2002 | 28 Jun 2005 | Sepracor Inc. | Methods of treating and preventing pain, anxiety, and incontinence using derivatives of (−)-venlafaxine |
| US6951873 | 3 Mar 2000 | 4 Oct 2005 | Pfizer Inc. | Methods for treating age-related behavioral disorders in companion animals |
| US6964966 | 23 Abr 2002 | 15 Nov 2005 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| US6974837 | 23 Oct 2002 | 13 Dic 2005 | Sepracor Inc. | Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors |
| US6974838 | 23 Mar 2004 | 13 Dic 2005 | Sepracor Inc. | Methods of treating or preventing pain using sibutramine metabolites |
| US6979463 | 19 Jun 2002 | 27 Dic 2005 | Schering Corporation | Stable extended release oral dosage composition |
| US6995168 | 29 May 2003 | 7 Feb 2006 | Euro-Celtique S.A. | Triazaspiro compounds useful for treating or preventing pain |
| US6998400 | 17 May 2002 | 14 Feb 2006 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
| US7019030 | 17 Jul 2003 | 28 Mar 2006 | Celgene Corporation | Immunotherapeutic agents |
| US7034059 | 28 Jun 2002 | 25 Abr 2006 | Sepracor Inc. | Methods of using norfluoxetine |
| US7064138 | 26 Feb 2003 | 20 Jun 2006 | Sepracor Inc. | Methods for treating irritable bowel syndrome using optically pure (-) norcisapride |
| US7071234 | 25 Mar 2003 | 4 Jul 2006 | Sepracor Inc. | Methods of treating or preventing erectile dysfunction |
| US7098206 | 17 May 2002 | 29 Ago 2006 | SmithKline Beecham Corporation | Pharmaceutically active morpholinol |
| US7105333 | 27 Mar 2002 | 12 Sep 2006 | Deadreon Corporation | Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon |
| US7112430 | 14 May 2002 | 26 Sep 2006 | Dendreon Corporation | Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| US7125703 | 13 Mar 2002 | 24 Oct 2006 | Dendreon Corporation | Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon |
| US7141696 | 21 May 2004 | 28 Nov 2006 | Bridge Pharma, Inc. | Smooth muscle spasmolytic agents |
| US7164023 | 31 Dic 2003 | 16 Ene 2007 | Wockhardt Limited | Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| US7172892 | 20 Mar 2002 | 6 Feb 2007 | Dendreon Corporation | Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon |
| US7176218 | 7 Ene 2005 | 13 Feb 2007 | ARYx Therapeutics | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| US7182953 | 11 Dic 2000 | 27 Feb 2007 | Celgene Corporation | Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders |
| US7186863 | 21 May 2004 | 6 Mar 2007 | TransForm Pharmaceuticals, Inc. | Sertraline compositions |
| US7189740 | 11 Abr 2003 | 13 Mar 2007 | Celgene Corporation | Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes |
| US7205413 | 1 May 2003 | 17 Abr 2007 | TransForm Pharmaceuticals, Inc. | Solvates and polymorphs of ritonavir and methods of making and using the same |
| US7211582 | 23 Nov 1999 | 1 May 2007 | Sepracor Inc. | Methods for treating urticaria using descarboethoxyloratadine |
| US7214683 | 16 Mar 1998 | 8 May 2007 | Sepracor Inc. | Compositions of descarboethoxyloratadine |
| US7214684 | 17 Nov 2004 | 8 May 2007 | Sepracor Inc. | Methods for the treatment of allergic rhinitis |
| US7229640 | 18 Dic 2001 | 12 Jun 2007 | SmithKline Beecham p.l.c. | Paroxetine controlled release compositions |
| US7259152 | 4 Jun 2001 | 21 Ago 2007 | Alfa Wasserman, Inc. | Methods and compositions using sulodexide for the treatment of diabetic nephropathy |
| US7276364 | 20 Nov 2000 | 2 Oct 2007 | Dendreon Corporation | Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| US7282509 | 23 Mar 2005 | 16 Oct 2007 | Aryx Therapeutics | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| US7291347 | 18 Ene 2006 | 6 Nov 2007 | Wyeth | Succinate salt of O-desmethyl-venlafaxine |
| US7323479 | 6 Nov 2003 | 29 Ene 2008 | Celgene Corporation | Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline |
| US7323480 | 24 May 2005 | 29 Ene 2008 | Metabolex, Inc. | Substituted triazoles as modulators of PPAR and methods of their preparation |
| US7326787 | 31 Ago 2006 | 5 Feb 2008 | ARYx Therapeutics, Inc. | Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders |
| US7329761 | 16 Nov 2004 | 12 Feb 2008 | Celgene Corporation | Substituted imides |
| US7351739 | 29 Abr 2005 | 1 Abr 2008 | Wellgen, Inc.
The Regents of the University of Minnesota
Rutgers, the State University of New Jersey | Bioactive compounds and methods of uses thereof |
| US7354948 | 6 Nov 2003 | 8 Abr 2008 | Celgene Corporation | Methods for treatment of chronic uveitis using cyclopropyl-n-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide |
| US7357891 | 30 Ene 2004 | 15 Abr 2008 | MonoSol Rx, LLC | Process for making an ingestible film |
| US7358246 | 7 Abr 2005 | 15 Abr 2008 | Wyeth | Thioamide derivatives as progesterone receptor modulators |
| US7393862 | 4 Oct 2005 | 1 Jul 2008 | Celgene Corporation | Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| US7393863 | 16 Ene 2007 | 1 Jul 2008 | Celgene Corporation | Methods of using N-{[2-(2,6-dioxo(3-piperidyl)-1,3-dioxoisoindolin-4-yl]methyl}cyclopropyl-carboxamide for the treatment and management of myelodysplastic syndromes |
| US7393957 | 20 Sep 2004 | 1 Jul 2008 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| US7405223 | 16 Ene 2001 | 29 Jul 2008 | Schering Corporation | Treating allergic and inflammatory conditions |
| US7414062 | 16 Jun 2005 | 19 Ago 2008 | Purdue Pharma L.P. | Triazaspiro compounds useful for treating or preventing pain |
| US7425292 | 14 Feb 2002 | 16 Sep 2008 | MonoSol Rx, LLC | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| US7438903 | 7 May 2004 | 21 Oct 2008 | NBTY, Inc. | Methods and compositions that enhance bioavailability of coenzyme-Q10 |
| US7465800 | 3 Sep 2004 | 16 Dic 2008 | Celgene Corporation | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| US7468363 | 8 Abr 2005 | 23 Dic 2008 | Celgene Corporation | Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| US7470435 | 17 Nov 2003 | 30 Dic 2008 | Andrx Pharmaceuticals, LLC | Extended release venlafaxine formulation |
| US7511071 | 7 Mar 2008 | 31 Mar 2009 | Wyeth | Thioamide derivatives as progesterone receptor modulators |
| US7514466 | 25 Abr 2005 | 7 Abr 2009 | Wyeth | Purification of progesterone receptor modulators |
| US7514583 | 30 May 2003 | 7 Abr 2009 | Proteotech, Inc. | Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| US7518017 | 31 Ene 2007 | 14 Abr 2009 | Idexx Laboratories | Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds |
| US7572812 | 20 Ene 2006 | 11 Ago 2009 | | Therapeutic agents useful for treating pain |
| US7582635 | 19 Dic 2003 | 1 Sep 2009 | | Therapeutic agents useful for treating pain |
| US7592335 | 12 Abr 2006 | 22 Sep 2009 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
| US7612096 | 23 Abr 2004 | 3 Nov 2009 | Celgene Corporation | Methods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindoline |
| US7618649 | 3 Nov 2003 | 17 Nov 2009 | Schering Corporation | Extended release oral dosage composition |
| US7626032 | 24 Abr 2008 | 1 Dic 2009 | Wockhardt Limited | Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| US7629466 | 25 Abr 2008 | 8 Dic 2009 | ARYx Therapeutics, Inc. | Synthetic methods and intermediates for steroisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders |
| US7642287 | 5 Ago 2005 | 5 Ene 2010 | Transform Pharmaceuticals, Inc. | Statin pharmaceutical compositions and related methods of treatment |
| US7659265 | 12 Feb 2009 | 9 Feb 2010 | Wyeth | Thioamide derivatives as progesterone receptor modulators |
| US7659282 | 12 Ene 2005 | 9 Feb 2010 | Avanir Pharmaceuticals, Inc. | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| US7659287 | 31 May 2007 | 9 Feb 2010 | Amgen Inc. | Benzamide derivatives and uses related thereto |
| US7666337 | 28 May 2004 | 23 Feb 2010 | MonoSol Rx, LLC | Polyethylene oxide-based films and drug delivery systems made therefrom |
| US7671093 | 27 May 2005 | 2 Mar 2010 | Transform Pharmaceuticals, Inc. | Mixed co-crystals and pharmaceutical compositions comprising the same |
| US7683063 | 14 Jun 2004 | 23 Mar 2010 | Purdue Pharma L.P. | Therapeutic agents useful for treating pain |
| US7696208 | 31 Ene 2006 | 13 Abr 2010 | Purdue Pharma L.P. | Therapeutic agents useful for treating pain |
| US7700341 | 2 Feb 2001 | 20 Abr 2010 | Dendreon Corporation | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| US7728025 | 28 Dic 2004 | 1 Jun 2010 | Banyu Pharmaceutical Co., Ltd. | 2-heteroaryl-substituted benzimidazole derivative |
| US7754723 | 28 Jun 2006 | 13 Jul 2010 | | Therapeutic agents useful for treating pain |
| US7767429 | 5 Mar 2004 | 3 Ago 2010 | Halozyme, Inc. | Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| US7767699 | 22 Dic 2005 | 3 Ago 2010 | Purdue Pharma, L.P. | Therapeutic agents useful for treating pain |
| US7772206 | 27 Feb 2009 | 10 Ago 2010 | Genzyme Corporation | Methods and compositions for the treatment of autoimmune disorders using clofarabine |
| US7772254 | 21 Mar 2006 | 10 Ago 2010 | Purdue Pharma L.P. | Therapeutic agents useful for treating pain |
| US7776861 | 23 Ene 2006 | 17 Ago 2010 | Purdue Pharma L.P. | Therapeutic agents useful for treating pain |
| US7776907 | 30 Oct 2003 | 17 Ago 2010 | Celgene Corporation | Methods for the treatment and management of macular degeneration using cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide |
| US7790905 | 29 Dic 2003 | 7 Sep 2010 | McNeil-PPC, Inc. | Pharmaceutical propylene glycol solvate compositions |
| US7799807 | 20 Mar 2006 | 21 Sep 2010 | Purdue Pharma L.P. | Therapeutic agents useful for treating pain |
| US7799820 | 29 Sep 2006 | 21 Sep 2010 | Banyu Pharmaceutical Co., Ltd. | 2-Heterocycle-substituted indole derivatives for treating diabetes and associated conditions |
| US7803366 | 25 Ago 2008 | 28 Sep 2010 | NBTY, Inc. | Methods and compositions that enhance bioavailability of coenzyme-Q10 |
| US7803786 | 16 Jun 2005 | 28 Sep 2010 | Transform Pharmaceuticals, Inc.
University of South Florida | Pharmaceutical co-crystal compositions and related methods of use |
| US7812169 | 30 Nov 2001 | 12 Oct 2010 | The Children's Medical Center Corporation | Method of synthesis of 4-amino-thalidomide enantiomers |
| US7820199 | 6 Oct 2005 | 26 Oct 2010 | Schering Corporation | Stable extended release oral dosage composition |
| US7824588 | 14 Abr 2008 | 2 Nov 2010 | Monosol RX, LLC | Method of making self-supporting therapeutic active-containing film |
| US7829081 | 4 Mar 2010 | 9 Nov 2010 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| US7842691 | 13 Abr 2003 | 30 Nov 2010 | Celgene Corporation | Method for the treatment of myelodysplastic syndromes using cyclopropanecarboxylic acid {2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-OXO-2,3-dihydro-1 H-isoindol-4-yl}-amide |
| US7846431 | 4 Mar 2010 | 7 Dic 2010 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| US7855217 | 15 Dic 2008 | 21 Dic 2010 | Celgene Corporation | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| US7863297 | 12 Nov 2007 | 4 Ene 2011 | Celgene Corporation | Methods of using 4-(amino)-2-(2,6-dioxo(3-piperidly))-isoindoline-3-dione for the treatment of myelodysplastic syndromes |
| US7871607 | 23 Feb 2005 | 18 Ene 2011 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| US7888092 | 30 Oct 2009 | 15 Feb 2011 | Dendreon Corporation | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| US7892776 | 5 May 2008 | 22 Feb 2011 | The Regents of the University of California | Screening assay to identify modulators of protein kinase A |
| US7893045 | 5 Ago 2008 | 22 Feb 2011 | Celgene Corporation | Methods for treating lymphomas in certain patient populations and screening patients for said therapy |
| US7902208 | 30 May 2008 | 8 Mar 2011 | Schering Corporation | Treating allergic and inflammatory conditions |
| US7910641 | 14 Dic 2006 | 22 Mar 2011 | Monosol Rx, LLC | PH modulated films for delivery of actives |
| US7927613 | 11 Sep 2003 | 19 Abr 2011 | University of South Florida
The Regents of the University of Michigan
Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions |
| US7928132 | 6 Ago 2004 | 19 Abr 2011 | Ohio University | Methods for the amelioration of episodes of acute or chronic ulcerative colitis |
| US7931915 | 19 Nov 2008 | 26 Abr 2011 | Andrx Pharmaceuticals, LLC | Extended release venlafaxine formulation |
| US7932421 | 12 Dic 2007 | 26 Abr 2011 | Amgen Inc. | N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases |
| US7964606 | 29 Jul 2010 | 21 Jun 2011 | Purdue Pharma L.P. | Therapeutic agents useful for treating pain |
| US7968569 | 15 May 2003 | 28 Jun 2011 | Celgene Corporation | Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| US7972618 | 20 Sep 2007 | 5 Jul 2011 | MonoSol Rx, LLC | Edible water-soluble film containing a foam reducing flavoring agent |
| US7977357 | 23 Jul 2008 | 12 Jul 2011 | Celgene Corporation | Polymorphic forms of 3-(4-amino-1-oxo-1, 3 dihydro-isoindo1-2-yl)-piperidine-2,6-dione |
| US7994177 | 21 Jul 2010 | 9 Ago 2011 | Purdue Pharma L.P. | Therapeutic agents useful for treating pain |
| US8008300 | 8 Jul 2009 | 30 Ago 2011 | Purdue Pharma L.P. | Therapeutic agents useful for treating pain |
| US8017150 | 22 Abr 2008 | 13 Sep 2011 | MonoSol Rx, LLC | Polyethylene oxide-based films and drug delivery systems made therefrom |
| US8026254 | 10 Nov 2009 | 27 Sep 2011 | Purdue Pharma, L.P. | Therapeutic agents useful for treating pain |
| US8030310 | 2 Mar 2010 | 4 Oct 2011 | Purdue Pharma, L.P. | Therapeutic agents useful for treating pain |
| US8058292 | 24 May 2010 | 15 Nov 2011 | Purdue Pharma L.P. | Therapeutic agents useful for treating pain |
| US8058443 | 15 Dic 2008 | 15 Nov 2011 | Celgene Corporation | Processes for preparing polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-YL))-piperidine-2,6-dione |
| US8063221 | 13 Mar 2007 | 22 Nov 2011 | Kyorin Pharmaceutical Co., Ltd. | Aminoquinolones as GSK-3 inhibitors |
| US8071591 | 10 Mar 2010 | 6 Dic 2011 | Kyorin Pharmaceutical Co., Ltd. | 7-cycloalkylaminoquinolones as GSK-3 inhibitors |
| US8101745 | 15 Dic 2005 | 24 Ene 2012 | The Regents of the University of California | Lung-targeted drugs |
| US8105586 | 15 Jun 2010 | 31 Ene 2012 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| US8110602 | 15 Jul 2009 | 7 Feb 2012 | Purdue Pharma L.P. | Compounds comprising heterocyclic-substituted piperidine for treating pain |
| US8129388 | 10 Jun 2011 | 6 Mar 2012 | Purde Pharma L.P. | Therapeutic agents useful for treating pain |
| US8138204 | 16 Jul 2007 | 20 Mar 2012 | ARYx Therapeutics, Inc. | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| US8138361 | 27 Dic 2006 | 20 Mar 2012 | The Trustees Of The University Of Pennsylvania
Acidophil, LLC | C-10 carbamates of taxanes |
| US8143286 | 15 Dic 2008 | 27 Mar 2012 | Celgene Corporation | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione) |
| US8153806 | 16 Jul 2010 | 10 Abr 2012 | The Children's Medical Center Corporation | Synthesis of 4-amino-thalidomide enantiomers |
| US8163957 | 16 Jul 2010 | 24 Abr 2012 | ProteoTech, Inc. | Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease |
| US8168635 | 20 Jun 2005 | 1 May 2012 | Human BioMolecular Research Institute | Modulators of central nervous system neurotransmitters |
| US8168672 | 2 Feb 2010 | 1 May 2012 | Wyeth | Thioamide derivatives as progesterone receptor modulators |
| US8178560 | 17 Jun 2010 | 15 May 2012 | Purdue Pharma L.P. | Therapeutic agents useful for treating pain |
| US8183290 | 20 Jul 2010 | 22 May 2012 | McNeil-PPC, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
| US8183381 | 10 Jul 2008 | 22 May 2012 | Metabolex Inc. | N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
| US8187630 | 2 Oct 2009 | 29 May 2012 | Schering-Plough Corporation | Extended release oral dosage composition |
| US8188118 | 19 Feb 2009 | 29 May 2012 | Celgene Corporation | Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies |
| US8193219 | 3 Oct 2011 | 5 Jun 2012 | Celgene Corporation | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| US8198262 | 19 Ago 2008 | 12 Jun 2012 | Celgene Corporation | Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione |
| US8198306 | 17 Dic 2009 | 12 Jun 2012 | Celgene Corporation | Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor |
| US8202517 | 20 Feb 2009 | 19 Jun 2012 | Halozyme, Inc. | Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| US8202999 | 6 Ene 2006 | 19 Jun 2012 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
| US8207200 | 8 May 2008 | 26 Jun 2012 | Celgene Corporation | Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantation |
| US8211428 | 5 Jul 2007 | 3 Jul 2012 | Torrey Pines Institute for Molecular Studies
Catalyst Biosciences, Inc. | Protease screening methods and proteases identified thereby |
| US8222257 | 30 Mar 2006 | 17 Jul 2012 | The Regents of the University of California | Phosphono-pent-2-en-1-yl nucleosides and analogs |
| US8227467 | 16 Feb 2010 | 24 Jul 2012 | Purdue Pharma L.P. | Therapeutic agents useful for treating pain |
| US8227484 | 8 Mar 2012 | 24 Jul 2012 | Avanir Pharmaceuticals, Inc. | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
